Cargando…
Mechanistic basis of post-treatment control of SIV after anti-α4β7 antibody therapy
Treating macaques with an anti-α4β7 antibody under the umbrella of combination antiretroviral therapy (cART) during early SIV infection can lead to viral remission, with viral loads maintained at < 50 SIV RNA copies/ml after removal of all treatment in a subset of animals. Depletion of CD8(+) lym...
Autores principales: | Wells, Chad R., Cao, Youfang, Durham, David P., Byrareddy, Siddappa N., Ansari, Aftab A., Ruddle, Nancy H., Townsend, Jeffrey P., Galvani, Alison P., Perelson, Alan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189501/ https://www.ncbi.nlm.nih.gov/pubmed/34106916 http://dx.doi.org/10.1371/journal.pcbi.1009031 |
Ejemplares similares
-
CD8(+) lymphocyte control of SIV infection during antiretroviral therapy
por: Cao, Youfang, et al.
Publicado: (2018) -
Early treatment with anti-α(4)β(7) antibody facilitates increased gut macrophage maturity in SIV-infected rhesus macaques
por: Johnson, Samuel D., et al.
Publicado: (2022) -
Early Treatment of SIV+ macaques with an α(4)β(7) mAb alters virus distribution and preserves CD4(+) T cells in later stages of infection
por: Santangelo, Philip J., et al.
Publicado: (2017) -
Antiretroviral therapy restores the homeostatic state of microglia in SIV‐infected rhesus macaques
por: Trease, Andrew J., et al.
Publicado: (2022) -
Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection
por: Byrareddy, Siddappa N., et al.
Publicado: (2014)